Your Browser is Not Supported
To ensure jobstore run smoothly, please use the latest version of the following supported browsers:
We are looking for an Internal Control and Audit Manager to lead the implementation of SOX project, assess internal controls, challenge current processes, advise on risk matters, and communicate with various business units to ensure compliance with policies and procedures.
Responsibilities
Our DNA is P-R-E-N-E-T-I-C-S. See what each word of our company name means:
Get to know us; Get to know our DNA!
Passion
Resilience
Empowerment
Integrity
Epic
Transparency
Ingenuity
Communication
Selfless
Official account of Jobstore.
Prenetics, a leading genomics-driven health sciences company, is revolutionizing prevention, early detection, and treatment. Our prevention arm, CircleDNA, uses whole exome sequencing to offer the world's most comprehensive consumer DNA test. Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, underscores our unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Lastly, ACT Genomics, our treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances our global impact on health, truly embodying our commitment to 'enhancing life through science.
Responsibilities:
Our DNA is P-R-E-N-E-T-I-C-S. See what each word of our company name means:
Get to know us; Get to know our DNA!
Passion
Resilience
Empowerment
Integrity
Epic
Transparency
Ingenuity
Communication
Selfless
Official account of Jobstore.
Insighta, a landmark Joint Venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Backed by world-class science from Prof. Lo, robust capital resources of US$100m from Prenetics, and led by successful entrepreneur Danny Yeung, the joint venture is poised to transform cancer screening. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Insighta presents an unprecedented opportunity to save lives and bolster Hong Kong's standing as a global hub for life sciences innovation.
Responsibilities:
Our DNA is P-R-E-N-E-T-I-C-S. See what each word of our company name means:
Get to know us; Get to know our DNA!
Passion
Resilience
Empowerment
Integrity
Epic
Transparency
Ingenuity
Communication
Selfless
Official account of Jobstore.